Hartmann's expansion programme boosts growth
This article was originally published in Clinica
The German Hartmann Group, which manufactures and markets surgical and hygiene products saw its sales rise by 10% to E1.27bn ($1.38bn) in 2002. Net income also rose by more than 50% compared with 2001, to E23.1m. This is partly due to the consolidation of the acquisition of an 80% stake in Kneipp medical company in 2001 that cost some E3m. "Our foreign expansion is paying dividends," said CEO Ulrich Hemel. He added that in addition to the 34 countries in which it is represented to date, the company would continue to look for opportunities in OECD countries and those with large populations.